Skip to main content
All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

Lobbying for KYVERNA THERAPEUTICS, INC. · Biopharmaceutical company focused on developing cell therapies for autoimmune diseases.

 Filing Registration
4th Quarter (Oct 1 - Dec 31) 2025 · California · posted Oct 23, 2025

Official filing document

 Lobbying activity 1
Health Issues

Issues related to developing cell therapies for patients.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem